1,2,3,4,4a,9b-Hexahydro-4a-aminoalkyldibenzofurans, a process for their preparation and their use as medicaments
申请人:HOECHST-ROUSSEL
PHARMACEUTICALS INCORPORATED
公开号:EP0230020A2
公开(公告)日:1987-07-29
This invention relates to 1,2,3,4,4a,9b-hexahydro-4a-aminoalkyldibenzofurans of the formula
where X is hydrogen, loweralkyl, F and Cl; R₁ is hydrogen, loweralkyl, arylloweralkyl, loweralkenyl, loweralkoxyloweralkyl, aryloxyloweralkyl, cycloalkylloweralkyl and heteroarylloweralkyl: R₂ is hydrogen, lower alkyl or R₁ and R₂ taken together with the N ring atom constitute a saturated or unsaturated heterocyclic ring having 5 or 6 members; R₃ is hydrogen, lower alkyl; n is an integer of 1 to 3; and the pharmaceutically acceptable acid addition salts thereof and where applicable the stereo, optical and geometrical isomers of the foregoing.
本发明涉及式 1,2,3,4,4a,9b-六氢-4a-氨基烷基二苯并呋喃
其中 X 是氢、低级烷基、F 和 Cl;R₁ 是氢、低级烷基、芳基低级烷基、低级烯基、低级烷氧基低级烷基、芳氧基低级烷基、环烷基低级烷基和杂芳基低级烷基:R₂ 是氢、低级烷基或 R₁ 和 R₂ 与 N 环原子一起构成具有 5 或 6 个成员的饱和或不饱和杂环;R₃ 是氢、低级烷基;n 是 1 至 3 的整数;以及它们的药学上可接受的酸加成盐,并酌情包括上述物质的立体异构体、光学异构体和几何异构体。